CRISPR Therapeutics
CRSP
#2966
Rank
C$6.12 B
Marketcap
$71.79
Share price
-0.50%
Change (1 day)
1.44%
Change (1 year)

Earnings for CRISPR Therapeutics (CRSP)

Earnings in 2024 (TTM): -C$0.37 Billion

According to CRISPR Therapeutics's latest financial reports the company's current earnings are C$0.20 Billion. In 2023 the company made an earning of -C$0.21 Billion, an increase over its 2022 earnings that were of -C$0.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CRISPR Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.37 Billion72.35%
2023 -C$0.21 Billion-76.83%
2022 -C$0.91 Billion-271.4%
2021 C$0.52 B-209.04%
2020 -C$0.49 Billion-617.12%
2019 C$93.6 M-140.93%
2018 -C$0.23 Billion146.86%
2017 -C$92.64 Million193.19%
2016 -C$31.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.18 Billion-52.45%๐Ÿ‡บ๐Ÿ‡ธ USA